Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and ...
GlobalData on MSN
HUTCHMED begins Phase III segment of metastatic PDAC treatment trial
HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...
Positive results from Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and ...
At the San Antonio Breast Cancer Symposium (SABCS), investigators outlined the rationale and design of the ERADICATE, a first ...
From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...
CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...
The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...
Patients with metastatic breast or advanced ovarian cancer spend about 7 hours per week on cancer-related tasks, including ...
In patients with BRCA2-mutated mCSPC, treatment with Akeega significantly reduced the risk of radiographic progression or death by 54%. The Food and Drug Administration (FDA) has approved Akeega ® ...
Ewing sarcoma is cancer that begins in the bones or soft tissues. Metastatic Ewing sarcoma is when the cancer has spread to another area of the body. Ewing sarcoma is a cancerous tumor that begins in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback